Producing Amyloid Beta-Peptides Using Coexpression with Affibody Ligand
Author Information
Author(s): Macao Bertil, Hoyer Wolfgang, Sandberg Anders, Brorsson Ann-Christin, Dobson Christopher M, Härd Torleif
Primary Institution: Department of Medical Biochemistry, University of Gothenburg
Hypothesis
Can coexpression with an affibody ligand improve the recombinant production of amyloid beta-peptides?
Conclusion
The coexpression of an engineered aggregation-inhibiting binding protein allows for the effective recombinant production of amyloidogenic Aβ peptides.
Supporting Evidence
- Coexpression of the affibody protein ZAβ3 allows for the overexpression of both major Aβ isoforms.
- The method yields 4 mg of Aβ(1–40) and 3 mg of Aβ(1–42) per liter of culture.
- Purified peptides were characterized by various techniques including NMR and SDS-PAGE.
Takeaway
Scientists found a new way to make a protein related to Alzheimer's disease that helps them study how it works without it clumping together.
Methodology
The study used a coexpression system in E. coli to produce amyloid beta-peptides by coexpressing the peptides with an affibody ligand that prevents aggregation.
Limitations
The method may still require optimization for different peptide variants and does not eliminate the presence of an N-terminal methionine.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website